Axogen, inc. to report 2023 fourth quarter and full-year financial results on march 5, 2024

Alachua, fla. and tampa, fla., feb. 13, 2024 (globe newswire) -- axogen, inc. (nasdaq: axgn), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced that it will report 2023 fourth quarter and full-year financial results on tuesday, march 5, 2024, before the market opens. axogen management will host an investment-community conference call and webcast at 8 a.m. et following the release.
AXGN Ratings Summary
AXGN Quant Ranking